JBT Marel Corp (NYSE:JBTM – Free Report) – Equities research analysts at William Blair issued their Q2 2025 earnings estimates for shares of JBT Marel in a research report issued on Wednesday, February 26th. William Blair analyst R. Sparenblek anticipates that the company will post earnings of $1.17 per share for the quarter. The consensus estimate for JBT Marel’s current full-year earnings is $5.21 per share. William Blair also issued estimates for JBT Marel’s Q3 2025 earnings at $1.62 EPS and FY2025 earnings at $6.00 EPS.
Separately, CL King started coverage on JBT Marel in a research note on Wednesday, January 22nd. They set a “buy” rating and a $143.00 price target for the company.
JBT Marel Stock Performance
Shares of JBTM opened at $131.43 on Thursday. The firm has a market cap of $4.19 billion, a PE ratio of 24.38, a price-to-earnings-growth ratio of 1.56 and a beta of 1.23. JBT Marel has a 12 month low of $82.64 and a 12 month high of $139.05. The company has a current ratio of 2.55, a quick ratio of 2.00 and a debt-to-equity ratio of 0.41.
JBT Marel (NYSE:JBTM – Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $1.70 earnings per share for the quarter, missing the consensus estimate of $1.80 by ($0.10). The firm had revenue of $467.60 million during the quarter, compared to analyst estimates of $490.23 million. JBT Marel had a return on equity of 10.16% and a net margin of 10.25%.
JBT Marel Company Profile
JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market.
Read More
- Five stocks we like better than JBT Marel
- Golden Cross Stocks: Pattern, Examples and Charts
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Transportation Stocks Investing
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for JBT Marel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBT Marel and related companies with MarketBeat.com's FREE daily email newsletter.
